On July 24, 2025, ReShape Lifesciences Inc. held a special stockholders meeting to vote on several proposals including a significant asset sale to Ninjour Health International Limited and a merger with Vyome Therapeutics, with the meeting adjourned to August 7, 2025 for further voting. Shareholder approvals included the issuance of shares for the merger and authorization for a potential reverse stock split.